CALOSYN PHARMA, INC. — Form D/A

CALOSYN PHARMA, INC. of Shreveport, LA, a company, filed a Form D amendment with the SEC on 2010-04-13. The offering totals $3.3M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Ross F BarrettDirectorBaton Rouge, LA
Joseph F LovettDirectorPlymouth Meeting, PA
Stephen F SnowdyDirectorMemphis, TN
David F WaddellDirectorShreveport, LA
Stephen F SnowdyExecutive OfficerMemphis, TN
Ross BarrettDirectorShreveport, LA
Joseph P LovettDirectorBaton Rouge, LA
Richard R BabbDirectorBaton Rouge, LA
Richard R BabbExecutive OfficerBaton Rouge, LA
David P WaddellDirectorShreveport, LA
Ross P BarrettDirectorShreveport, LA
Ross P BarrettExecutive OfficerShreveport, LA
Stephen SnowdyDirectorBrookhaven, GA
Stephen SnowdyExecutive OfficerBrookhaven, GA
William R GrimesDirectorKingwood, TX
William R GrimesExecutive OfficerKingwood, TX
Mike ShermanDirectorDurham, NC
Joseph LovettDirectorHouston, TX
David WaddellDirectorAtlanta, 2Q
Martin BeckerDirectorSharon, MA
Martin BeckerExecutive OfficerSharon, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2024-03-07D$2.0M$750K
2012-02-29D$2.1M$310K
2009-04-13D$400K$400K

More